Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Robert D Inman
Golimumab Administered Subcutaneously Every 4 Weeks in Ankylosing Spondylitis: 104-Week Results of the GO-RAISE Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Sarilumab for the Treatment of Ankylosing Spondylitis: Results of a Phase II, Randomised, Double-Blind, Placebo-Controlled Study (ALIGN)
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
Safety and Efficacy of Golimumab Administered Intravenously in Adults With Ankylosing Spondylitis: Results Through Week 28 of the GO-ALIVE Study
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Ankylosing Spondylitis--Experience With a Self Administered Questionnaire: An Analytical Study.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Celecoxib Versus Diclofenac for the Treatment of Ankylosing Spondylitis: 12-Week Randomized Study in Norwegian Patients
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Sustained Durability and Tolerability of Etanercept in Ankylosing Spondylitis for 96 Weeks
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Ankylosing Spondylitis
Ankylosing Spondylitis
Ankylosing Spondylitis
Ankylosing Spondylitis
Withdrawal of Infliximab Therapy in Ankylosing Spondylitis in Persistent Clinical Remission, Results From the REMINEA Study
Arthritis Research & Therapy
